Professional Documents
Culture Documents
1 s2.0 S0001706X10000860 Main
1 s2.0 S0001706X10000860 Main
Postgrado de Inmunologa, Instituto de Investigaciones Clnicas, Facultad de Medicina, Universidad del Zulia, Apartado Postal 23, Maracaibo, Venezuela
a r t i c l e i n f o
Article history:
Received 23 December 2009
Accepted 1 April 2010
Available online 9 April 2010
Keywords:
Cyclospora cayetanensis
Cyclosporiasis
Epidemiology
Risk factors
Transmission
Review
a b s t r a c t
Cyclospora cayetanensis is an intestinal coccidian protozoon that has emerged as an important cause
of endemic or epidemic diarrhoeal illness in children and adults worldwide. Humans appear to be the
only natural hosts. However, the role of animals as natural reservoirs is uncertain but of increasing
concern. Human-to-human spread of the parasite occurs indirectly via the environment through oocysts
in contaminated water, food or soil. In endemic areas, risk factors associated with the infection include
contaminatedwater or food, contact withsoil or animals, type of sanitationandlowsocioeconomic status.
Infections linked to soil contact provide reasons to believe that this route of spread may be more common
than realised in disadvantaged community settings. C. cayetanensis is an important cause of travellers
diarrhoea and numerous large foodborne outbreaks associated with the globalisation of the food supply
andimportationof fruits andvegetables fromdeveloping countries have occurred. Waterborne outbreaks
have also been reported. Implementation of measures to prevent or control the spread of Cyclospora
oocysts in the environment is critical. In endemic areas, the most important steps to prevent infection are
improving environmental sanitation and health education. Signicant gaps remain in our understanding
of the epidemiology of human cyclosporiasis that highlight the need for continued research in several
aspects of C. cayetanensis.
2010 Elsevier B.V. All rights reserved.
Contents
1. Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
1.1. Historical perspective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
1.2. Human cyclosporiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
1.3. Aim of this review. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
2. Biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
2.1. Current taxonomy and phylogeny . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
2.2. Life cycle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
2.3. Structure and survival of the infective stage. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
2.4. Infectivity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
2.5. Environmental occurrence of oocysts and transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
3. Epidemiology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
3.1. Distribution of human cyclosporiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
3.2. Geographic distribution and prevalence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
3.3. Age and sex distribution. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 186
3.4. Seasonal distribution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
3.5. Reservoirs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
3.6. Sources and routes of transmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
3.6.1. Waterborne transmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
3.6.2. Foodborne transmission. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
3.6.3. Soil transmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
3.6.4. Zoonotic transmission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
3.6.5. Airborne transmission. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
4. Prevention and control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
C within 14 days
(Ortega et al., 1998).
2.3. Structure and survival of the infective stage
Oocysts are small and spheroidal in shape with a diameter of
7.79.9m. With the modied acid-fast stain, some oocysts are
open and others not opened to the stain. Some stain dark red and
have variable number of dark inclusion bodies, whereas others do
not stain at all and appear as transparent spheres. Under epiuo-
rescence illumination, they have the ability to autouoresce blue
or green under a 365nm or a 490nm dichromatic lter (Ortega et
al., 1993; Sterling and Ortega, 1999). From transmission electron
microscopy studies, a sporulated oocyst is described as possessing
a two-layered oocyst wall (63 and 50nm thick, respectively) sur-
roundingtwosporocysts, eachwith62-nm-thickwalls surrounding
a plasma membrane. Sporocyst has Stieda and substieda bodies
and a residuum with spherical globules. Each sporocyst has two
sporozoites (Ortega et al., 1993, 1994).
Coccidia oocysts can persist for long periods of time in the
environment, maintaining their infectivity even under harsh envi-
ronmental conditions (Manseld and Gajadhar, 2004; Sinski and
Behnke, 2004). Naturally occurring Cyclospora oocysts may survive
for extendedperiods inthe environment, giventhe markedseason-
ality of infection in endemic regions (Herwaldt and Beach, 1999).
Cyclospora oocysts survive inwater at 4
C
for 7 days (Smith et al., 1997; Ortega et al., 1998). Oocysts cannot
be induced to sporulate after freezing at 18
C
for up to 4 days. Few oocysts sporulated at 50